Results 121 to 130 of about 26,766 (270)

Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?

open access: yesInternational Journal of Cancer, Volume 157, Issue 5, Page 964-979, 1 September 2025.
What's new? Currently, no published data on homologous recombination deficiency (HRD) testing in the setting of molecular tumor boards exist. This study in a cohort of 237 patients encompassing 24 different tumor entities assessed by a molecular tumor board shows that inactivating alterations of BRCA1/2 are not always associated with an elevated ...
Christoph Schubart   +26 more
wiley   +1 more source

Overexpression of Wild-type p53 in Lichen Sclerosus adjacent to Human Papillomavirus-negative Vulvar Cancer [PDF]

open access: bronze, 2002
Katrina Vanin   +4 more
openalex   +1 more source

Definitive Chemoradiotherapy for Vulvar Cancer

open access: yesInternational Journal of Gynecological Cancer, 2016
This study aimed to evaluate clinical outcomes after chemoradiation (CRT) for the definitive (nonsurgical) treatment of vulvar cancer.Women with vulvar cancer treated with definitive CRT at a single academic institution between 1994 and 2015 were retrospectively identified.
Laura J. Havrilesky   +3 more
openaire   +3 more sources

Effectiveness of a Structured Educational Intervention on Parents’ Knowledge, Perception, and Acceptance Towards Human Papillomavirus Vaccine

open access: yesPublic Health Challenges, Volume 4, Issue 3, September 2025.
ABSTRACT Background Cervical cancer is one of the common cancer among women worldwide, with high mortality and morbidity rates. The human papillomavirus (HPV) vaccine is one of several preventative options for cervical cancer. The HPV vaccine is just introduced in Nepal and is still not included in the national immunization schedule.
Radha Devi Dhakal   +3 more
wiley   +1 more source

Klinische Epidemiologie maligner gynäkologischer Tumoren [PDF]

open access: yes, 2018
Die systematische Erfassung aller Patientinnen und Patienten im Einzugsgebiet des Tumorregisters München ermöglicht die bevölkerungsbezogene Aufarbeitung von Fragestellungen zur klinischen Epidemiologie von Krebserkrankungen.
Rottmann, Miriam
core  

Management Challenges of a Rare Case of a High‐Grade T‐Cell Lymphoma of the Vulva in a Premenopausal HIV‐Infected Woman: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 8, August 2025.
ABSTRACT Primary vulvar lymphoma is an exceptionally rare malignancy, comprising less than 1% of all vulvar cancers and an even smaller fraction of extranodal non‐Hodgkin lymphomas. Among these, high‐grade T‐cell lymphoma is exceedingly uncommon, with limited cases reported in the literature.
John Lugata   +7 more
wiley   +1 more source

A case of synchronous double primary vulvar cancer and PET-negative renal cell carcinoma [PDF]

open access: gold, 2007
Si Won Jeon   +5 more
openalex   +1 more source

Female Urethral Adenocarcinoma Posing a Diagnostic Challenge

open access: yesClinical Case Reports, Volume 13, Issue 8, August 2025.
ABSTRACT Generally, urethral malignancies are uncommon urological tumors that are more frequent in women than in men. The etiology of female urethral adenocarcinoma is yet unknown. Recurrent UTIs and urethral diverticula are two common risk factors linked to it. Clinical presentations can differ and are not always specific.
Omar Darboe   +7 more
wiley   +1 more source

Vulvar cancer. The contribution of radiotherapy to the treatment of the disease

open access: yesСибирский онкологический журнал
The aim of the study was to analyze and summarize the available literature data on the modern radiotherapy techniques, indications for radiotherapy (preoperative, radical, postoperative radiation therapy), treatment volumes at different disease stages ...
P. A. Lushnikova   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy